Form 4: Charles River Laboratories International CEO Reports Stock T
Insider Transaction (Form 4)
Birgit Girshick, Chief Executive Officer and a Director of Charles River Laboratories International, Inc., reported a transaction in 528 shares of common stock on August 19, 2026.
Summary
- Bona fide gift: disposed of 528 Common Stock on August 19, 2026; holds 35,485 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Birgit Girshick — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-19 | Bona fide gift | Common Stock | 528 | — | — | 35,485 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-19 | Bona fide gift (528 shares) |
Keywords
insider transaction, Form 4, CRL, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., neutral, Birgit Girshick
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.